Oscar Health, Inc.
NYSE:OSCRMedical - Healthcare Plans
+$0.05 today
- Market cap
- $7.15B
- Beta
- 2.39
- P/E (TTM)
- -214.2
- EPS (TTM)
- -$0.13
Volume 7.38M
Average 7.51M
OSCR Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Oscar Health, Inc.NYSE: OSCR
Net Income · Q2 FY2026 · quarter ended Jun 2026
Net income turns positive
Q2 FY2026 net income was $361.83M, compared with -$228.49M a year earlier. Trailing-twelve-month net income was $550.93M. Over 3 fiscal years it compounded at -10.1% a year.
Context
- Net income amounted to 3.8% of revenue in FY2025, up 3.5 pp from a year earlier.
- Net income increased in 2 of the last 3 fiscal years.
What to watch
Whether net income reaches the consensus estimate from 6 analysts of $625.6M (+241.2%) for the fiscal year ending Dec 2026, a step up from the -1795.6% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $361.83M-46.7% QoQ
- Last fiscal yearDec 2025
- -$442.9M-1795.6% YoY
- LTMJun 2026
- $550.93M+443.4% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +258.4% | -63.8% | -322.1 pp |
| 1 year | -1795.6% | +241.2% | +2036.8 pp |
| 3-year CAGR | -10.1% | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- (442.9M) USD
- Year-over-year change
- -1795.6%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (442.9M) | -1795.6% |
| FY2024 | 2024-12-31 | 26.12M | +109.7% |
| FY2023 | 2023-12-31 | (270.59M) | +55.6% |
| FY2022 | 2022-12-31 | (609.55M) | -6.7% |
| FY2021 | 2021-12-31 | (571.43M) | — |
Net Income vs competitors
How OSCR compares with its peers on the latest reported figures
- OSCR's LTM Jun 2026 net income of $550.93M is the 5th largest of the 8 companies compared; the peer median is $19.79M.
- Its year-over-year change of +443.4% is the highest of 8, against a peer median of -7.7%.
- Net income amounts to 3.6% of revenue for OSCR, versus a peer median of 1.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $6.71B | +2.4% | -2.5% | 2.3% | |
| LTM Jun 2026 | $6.1B | +35.6% | -26.4% | 1.5% | |
| LTM Jun 2026 | $5.11B | -350.3% | — | 2.6% | |
| LTM Sep 2026 | $5.1B | -7.7% | -2.0% | 2.5% | |
| LTM Jun 2026 | $550.93M | +443.4% | -10.1% | 3.6% | |
| LTM Sep 2026 | $48M | -105.4% | -15.8% | 0.1% | |
| LTM Mar 2026 | $19.79M | +121.8% | -83.1% | 0.5% | |
| LTM Jun 2026 | $18.36M | -57.4% | -36.8% | 0.7% | |
| Peer median (excluding OSCR) | $19.79M | -7.7% | -21.1% | 1.5% | |
Competitors are the stored peer set for OSCR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (571.43M) | (609.55M) | (270.59M) | 26.12M | (442.9M) |
| Depreciation & Amortization | 14.61M | 15.28M | 30.69M | 32.15M | 28.89M |
| Deferred Income Tax | (101K) | (165K) | 58K | (2.34M) | 2.45M |
| Stock-Based Compensation | 86.3M | 112.33M | 159.68M | 109.82M | 87.65M |
| Change in Working Capital | 247.7M | 855M | (192.09M) | 838.86M | 1.46B |
| Accounts Receivables | 80.45M | (551.15M) | 636.23M | (177.52M) | 98.57M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (39.46M) | 280.23M | (395.81M) | 133.09M | 167.72M |
| Other Working Capital | 206.71M | 1.13B | (432.51M) | 883.29M | 1.19B |
| Other Non-Cash Items | 41.19M | 7.46M | 86K | (26.42M) | (40.24M) |
| Operating Cash Flow | (181.75M) | 380.35M | (272.16M) | 978.19M | 1.09B |
| Capital Expenditures | (25.89M) | (29.01M) | (25.58M) | (27.9M) | (36.37M) |
| Acquisitions (Net) | 7.23M | 0 | 0 | 0 | 0 |
| Purchases of Investments | (1.81B) | (1.19B) | (836.98M) | (2.13B) | (1.01B) |
| Sales of Investments | 1.05B | 994.08M | 1.44B | 770.04M | 804.96M |
| Other Investing Activities | (555K) | 1.12M | (2.28M) | 3.93M | 4.28M |
| Investing Cash Flow | (774.52M) | (226.52M) | 577.19M | (1.39B) | (241.06M) |
| Debt Repayment | (153.17M) | 305M | 0 | 0 | 348.21M |
| Common Stock Issued | 1.35B | 1.3M | 3.96M | 68.39M | 55.03M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 43.56M | (5.19M) | 2.49M | 0 | (4.04M) |
| Financing Cash Flow | 1.24B | 301.11M | 6.45M | 68.39M | 399.21M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 282.45M | 454.94M | 311.47M | (340.85M) | 1.25B |
| Free Cash Flow | (207.63M) | 351.34M | (297.74M) | 950.3M | 1.06B |
Oscar Health, Inc.
NYSE:OSCR
Intrinsic Alpha fair value
Locked
Current Price
$27.57
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.